Anticoagulation Management After CABG Surgery

Recommended Anticoagulation Strategy Post-CABG

• The American College of Cardiology recommends aspirin (81-325 mg daily) as the antiplatelet therapy after CABG surgery for patients without atrial fibrillation 1, 3
• Aspirin should be initiated within 6 hours postoperatively and then continued indefinitely to reduce saphenous vein graft closure and adverse cardiovascular events, with a strength of evidence based on clinical guidelines 3
• Soluble aspirin may be preferred over enteric-coated aspirin for optimal platelet inhibition, according to the American Heart Association 2
• Dosing regimens ranging from 100 mg daily to 325 mg daily appear to be efficacious for maintaining graft patency, as supported by the American College of Cardiology 2

Timing Considerations

• When given within 48 hours after CABG, aspirin has been shown to reduce subsequent rates of mortality, MI, stroke, renal failure, and bowel infarction, with a high level of evidence 2
• The benefit of postoperative aspirin on saphenous vein graft patency is lost when initiated more than 48 hours after surgery, based on recommendations from the American Heart Association 2

Why Eliquis (Apixaban) is Not Appropriate

• The American College of Cardiology states that Eliquis (apixaban) is a direct oral anticoagulant (DOAC) primarily indicated for patients with atrial fibrillation to prevent stroke and systemic embolism, with a strong recommendation 4
• There are no guideline recommendations supporting the use of apixaban in patients without atrial fibrillation following CABG surgery, as stated by the American College of Cardiology 5, 6

Special Considerations for This Patient

Barrett's Esophagus and Pantoprazole

• The American College of Cardiology notes that pantoprazole use for Barrett's esophagus does not necessitate the use of apixaban or other DOACs 5, 6
• While proton pump inhibitors like pantoprazole may reduce the risk of gastrointestinal bleeding with antiplatelet therapy, they do not require switching from standard post-CABG antiplatelet therapy to anticoagulation, according to the American Heart Association 2

Alternative Options if Aspirin Cannot Be Used

• If the patient is truly aspirin-intolerant or allergic, clopidogrel 75 mg daily is a reasonable alternative, as recommended by the American College of Cardiology 2
• Ticlopidine could be considered but offers no advantage over aspirin except as an alternative in truly aspirin-allergic patients, and carries a risk of neutropenia requiring blood count monitoring, with a moderate level of evidence 2

Duration of Antiplatelet Therapy

• Aspirin should be continued indefinitely after CABG to maintain graft patency and reduce adverse cardiovascular events, with a strong recommendation from the American College of Cardiology 3
• For patients with stable ischemic heart disease who had CABG surgery without a history of acute coronary syndrome, aspirin should be continued for at least 1 year post-CABG, after which antiplatelet therapy is still recommended but could potentially be stopped if there are significant bleeding concerns, as stated by the American College of Cardiology 6

Important Caveats and Pitfalls

• The American College of Chest Physicians notes that post-CABG management for patients with and without atrial fibrillation requires different antithrombotic strategies, with a high level of evidence 7
• Avoid initiating aspirin later than 48 hours after surgery as this reduces its effectiveness for graft patency, based on recommendations from the American Heart Association 2
• Remember that dipyridamole and warfarin add nothing to the effect of aspirin on saphenous vein graft patency, and warfarin may increase bleeding risk compared with antiplatelet agents, with a moderate level of evidence 2
• Ensure that statin therapy is also initiated or continued post-CABG, as this is a Class I recommendation for all CABG patients without contraindications, according to the American College of Cardiology 1, 3